Characterizing Pulmonary Function Test Changes for Patients With Lung Cancer Treated on a 2-Institution, 4-Dimensional Computed Tomography-Ventilation Functional Avoidance Prospective Clinical Trial

Four-dimensional computed tomography (4DCT)–ventilation-based functional avoidance uses 4DCT images to generate plans that avoid functional regions of the lung with the goal of reducing pulmonary toxic effects. A phase 2, multicenter, prospective study was completed to evaluate 4DCT-ventilation func...

Full description

Saved in:
Bibliographic Details
Published in:Advances in radiation oncology 2023-03, Vol.8 (2), p.101133, Article 101133
Main Authors: Miller, Ryan, Castillo, Richard, Castillo, Edward, Jones, Bernard L., Miften, Moyed, Kavanagh, Brian, Lu, Bo, Werner-Wasik, Maria, Ghassemi, Nader, Lombardo, Joseph, Barta, Julie, Grills, Inga, Rusthoven, Chad G., Guerrero, Thomas, Vinogradskiy, Yevgeniy
Format: Article
Language:English
Subjects:
Scientific
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Four-dimensional computed tomography (4DCT)–ventilation-based functional avoidance uses 4DCT images to generate plans that avoid functional regions of the lung with the goal of reducing pulmonary toxic effects. A phase 2, multicenter, prospective study was completed to evaluate 4DCT-ventilation functional avoidance radiation therapy. The purpose of this study was to report the results for pretreatment to posttreatment pulmonary function test (PFT) changes for patients treated with functional avoidance radiation therapy. Patients with locally advanced lung cancer receiving chemoradiation were accrued. Functional avoidance plans based on 4DCT-ventilation images were generated. PFTs were obtained at baseline and 3 months after chemoradiation. Differences for PFT metrics are reported, including diffusing capacity for carbon monoxide (DLCO), forced expiratory volume in 1 second (FEV1), and forced vital capacity (FVC). PFT metrics were compared for patients who did and did not experience grade 2 or higher pneumonitis. Fifty-six patients enrolled on the study had baseline and posttreatment PFTs evaluable for analysis. The mean change in DLCO, FEV1, and FVC was –11.6% ± 14.2%, –5.6% ± 16.9%, and –9.0% ± 20.1%, respectively. The mean change in DLCO was –15.4% ± 14.4% for patients with grade 2 or higher radiation pneumonitis and –10.8% ± 14.1% for patients with grade
ISSN:2452-1094
2452-1094
DOI:10.1016/j.adro.2022.101133